Agent Trial
Trading Prediction Markets AI Agent Context Fastest News API Agent Trial Log In Sign Up
News Wire / health

Smart Drug Shrinks Tumors in Early Trials

developing Bluesky Social Drug 57m35m Impact 8
A new drug that prevents cancer cells from evading treatment has shown promise in early trials. The drug has shrunk tumors by at least 30% in six common cancer types. Further trials are underway to assess its efficacy.

Topics

cancer treatment drug trials immunotherapy

Developing

  1. 882d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 882d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 882d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 882d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

Bluesky Social

“A smart drug that stops cancer cells “hiding” from treatment can shrink tumours by at least 30% in six of the world’s most common forms of the disease, early trial results show.”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade